Multiple studies suggest that PRL and GH promotes breast cancer growth (Tworoger et al., 2006; Bernichtein et al., 2010; Conway-Campbell et al., 2007), leading to wide interest in PRLR/GHR as a potential target for breast cancer therapy (Damiano et al., 2013). This evidence concerns the gene GHR and breast carcinoma.